ventolin 500micrograms/1ml solution for injection ampoules
glaxosmithkline uk ltd - salbutamol sulfate - solution for injection - 500microgram/1ml
salbutamol neutec 2.5 mg/2.5 ml nebuliser solution
neutec inhaler ireland limited - salbutamol sulfate - nebuliser solution - salbutamol
asmol cfc-free inhaler salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose
alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
ventolin inhaler cfc-free salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
ventolin 500microgram/1ml injection ampoule
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.6 mg/ml (equivalent: salbutamol, qty 0.5 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sulfuric acid; water for injections - indications as at 3rd december 2002: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.
ventolin inhaler cfc-free salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose (with counter)
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
zempreon cfc-free inhaler salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose (with counter)
alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
asmol cfc-free inhaler salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose (with counter)
alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.
butamol 5 salbutamol 5mg/2.5ml (as sulfate) inhalation ampoules
aspen pharma pty ltd - salbutamol sulfate -
butamol 2.5 salbutamol 2.5mg/2.5ml (as sulfate) inhalation ampoules
aspen pharma pty ltd - salbutamol sulfate -